![Trent Carrier](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Trent Carrier
Plus aucun poste en cours
Profil
Trent Carrier currently serves as Executive Director-Business Strategy at Biologics Consulting Group, Inc., Director at NERx Biosciences, Inc., Chief Operating Officer at L7 Informatics, Inc. since 2019, Operating Partner at BroadOak Capital Partners LLC since 2024, and President at Carolina Molecular, Inc. Formerly, Dr. Carrier was Chief Executive Officer & Director at CytoSen Therapeutics, Inc. Education includes a graduate degree from the University of California, Berkeley in 1998 and an MBA from the University of Virginia Darden School of Business in 2010.
Postes actifs de Trent Carrier
| Sociétés | Poste | Début |
|---|---|---|
Biologics Consulting Group, Inc.
 Biologics Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides regulatory and product development advice for drugs and device products | Corporate Officer/Principal | 12/08/2011 |
L7 Informatics, Inc.
 L7 Informatics, Inc. Packaged SoftwareTechnology Services Develops integrated informatics platforms for labs | Directeur des opérations | 01/10/2019 |
NERx Biosciences, Inc.
 NERx Biosciences, Inc. BiotechnologyHealth Technology Engages in discovery and development of therapeutics for cancer | Directeur/Membre du Conseil | - |
BroadOak Capital Partners LLC
 BroadOak Capital Partners LLC Investment ManagersFinance Broadoak capital partners LLC invests in companies located in the United States. The firm focuses on life sciences tools, diagnostics, and biopharma services sectors. It provides financing for growth stage capital requirements. | Private Equity Investor | 01/12/2024 |
Anciens postes connus de Trent Carrier
| Sociétés | Poste | Fin |
|---|---|---|
CytoSen Therapeutics, Inc.
 CytoSen Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops nanoparticle-based technology and therapeutics | Directeur Général | - |
Formation de Trent Carrier
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
91
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Biologics Consulting Group, Inc.
Biologics Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides regulatory and product development advice for drugs and device products | Commercial Services |
L7 Informatics, Inc.
L7 Informatics, Inc. Packaged SoftwareTechnology Services Develops integrated informatics platforms for labs | Technology Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BroadOak Capital Partners LLC
BroadOak Capital Partners LLC Investment ManagersFinance Broadoak capital partners LLC invests in companies located in the United States. The firm focuses on life sciences tools, diagnostics, and biopharma services sectors. It provides financing for growth stage capital requirements. | Finance |
University of Virginia Darden School of Business
 University of Virginia Darden School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CytoSen Therapeutics, Inc.
CytoSen Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops nanoparticle-based technology and therapeutics | Commercial Services |
NERx Biosciences, Inc.
NERx Biosciences, Inc. BiotechnologyHealth Technology Engages in discovery and development of therapeutics for cancer | Health Technology |
